- Home
- EVRI vs DYN Comparison
EVRI vs DYN Comparison
Compare EVRI & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVRI
- DYN
- Stock Information
- Founded
- EVRI 1998
- DYN 1984
- Country
- EVRI United States
- DYN United States
- Employees
- EVRI N/A
- DYN N/A
- Industry
- EVRI Services-Misc. Amusement & Recreation
- DYN Medicinal Chemicals and Botanical Products
- Sector
- EVRI Consumer Discretionary
- DYN Health Care
- Exchange
- EVRI Nasdaq
- DYN Nasdaq
- Market Cap
- EVRI 1.2B
- DYN 1.3B
- IPO Year
- EVRI 2005
- DYN 2020
- Fundamental
- Price
- EVRI $14.12
- DYN $11.96
- Analyst Decision
- EVRI Hold
- DYN Strong Buy
- Analyst Count
- EVRI 4
- DYN 12
- Target Price
- EVRI $12.83
- DYN $47.00
- AVG Volume (30 Days)
- EVRI 1.4M
- DYN 2.5M
- Earning Date
- EVRI 05-12-2025
- DYN 05-08-2025
- Dividend Yield
- EVRI N/A
- DYN N/A
- EPS Growth
- EVRI N/A
- DYN N/A
- EPS
- EVRI 0.16
- DYN N/A
- Revenue
- EVRI $749,853,000.00
- DYN N/A
- Revenue This Year
- EVRI $1.64
- DYN N/A
- Revenue Next Year
- EVRI $3.25
- DYN N/A
- P/E Ratio
- EVRI $88.13
- DYN N/A
- Revenue Growth
- EVRI N/A
- DYN N/A
- 52 Week Low
- EVRI $6.47
- DYN $6.36
- 52 Week High
- EVRI $14.15
- DYN $47.45
- Technical
- Relative Strength Index (RSI)
- EVRI 68.54
- DYN 55.03
- Support Level
- EVRI $14.05
- DYN $11.52
- Resistance Level
- EVRI $14.14
- DYN $12.34
- Average True Range (ATR)
- EVRI 0.04
- DYN 0.78
- MACD
- EVRI -0.01
- DYN -0.02
- Stochastic Oscillator
- EVRI 65.00
- DYN 42.47
About EVRI Everi Holdings Inc.
Everi Holdings Inc provides entertainment and technology solutions for the casino, interactive, and gaming industry. It operates in two segments, namely Games and Financial Technology Solutions (FinTech). Enveri Games provides gaming operators with gaming technology products and services, which include gaming machines, slot machines, leased gaming equipment, and other products and services. Enveri FinTech provides gaming operators with financial technology products and services, which include services and equipment that facilitate casino patrons to access cash at gaming facilities through automated teller machines, point of sale debit card purchases, and others.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.